共 50 条
- [22] Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review Journal of Neuroimmune Pharmacology, 2020, 15 : 350 - 358
- [23] Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11): : 1048 - 1057
- [26] In patients hospitalized for COVID-19, does baricitinib reduce 28-days mortality compared to standard treatment, and is it safe? REVUE DE MEDECINE INTERNE, 2022, 43 (10): : 634 - 635
- [28] Nursing care for hospitalized patients in COVID-19 units ENFERMERIA CLINICA, 2021, 31 : S49 - S54
- [30] Tocilizumab demonstrates superiority in decreasing C-reactive protein levels in hospitalized COVID-19 patients, compared to standard care treatment alone MICROBIOLOGY SPECTRUM, 2024, 12 (06):